1. Home
  2. BCAX vs GBX Comparison

BCAX vs GBX Comparison

Compare BCAX & GBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAX
  • GBX
  • Stock Information
  • Founded
  • BCAX 2018
  • GBX 1974
  • Country
  • BCAX United States
  • GBX United States
  • Employees
  • BCAX N/A
  • GBX N/A
  • Industry
  • BCAX
  • GBX Railroads
  • Sector
  • BCAX
  • GBX Industrials
  • Exchange
  • BCAX NYSE
  • GBX Nasdaq
  • Market Cap
  • BCAX 1.3B
  • GBX 1.6B
  • IPO Year
  • BCAX 2024
  • GBX N/A
  • Fundamental
  • Price
  • BCAX $20.17
  • GBX $65.08
  • Analyst Decision
  • BCAX Strong Buy
  • GBX Hold
  • Analyst Count
  • BCAX 4
  • GBX 3
  • Target Price
  • BCAX $41.00
  • GBX $60.00
  • AVG Volume (30 Days)
  • BCAX 274.3K
  • GBX 399.1K
  • Earning Date
  • BCAX 11-12-2024
  • GBX 01-03-2025
  • Dividend Yield
  • BCAX N/A
  • GBX 1.84%
  • EPS Growth
  • BCAX N/A
  • GBX 163.31
  • EPS
  • BCAX N/A
  • GBX 4.96
  • Revenue
  • BCAX N/A
  • GBX $3,544,700,000.00
  • Revenue This Year
  • BCAX N/A
  • GBX $1.11
  • Revenue Next Year
  • BCAX N/A
  • GBX N/A
  • P/E Ratio
  • BCAX N/A
  • GBX $13.12
  • Revenue Growth
  • BCAX N/A
  • GBX N/A
  • 52 Week Low
  • BCAX $18.33
  • GBX $36.23
  • 52 Week High
  • BCAX $28.09
  • GBX $67.22
  • Technical
  • Relative Strength Index (RSI)
  • BCAX N/A
  • GBX 77.98
  • Support Level
  • BCAX N/A
  • GBX $64.82
  • Resistance Level
  • BCAX N/A
  • GBX $67.22
  • Average True Range (ATR)
  • BCAX 0.00
  • GBX 1.41
  • MACD
  • BCAX 0.00
  • GBX 0.24
  • Stochastic Oscillator
  • BCAX 0.00
  • GBX 93.67

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

About GBX Greenbrier Companies Inc. (The)

Greenbrier Companies Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe, marine barges in North America and provides wheel services, railcar refurbishment, and parts, leasing and other services to the railroad. Its segments include Manufacturing, Maintenance Services and Leasing & Management Services. The company generates a majority of its revenue from the manufacturing segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: